...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >Challenges in Brain Death Determination and Apnea Testing for Patients with COVID-19
【24h】

Challenges in Brain Death Determination and Apnea Testing for Patients with COVID-19

机译：Covid-19患者脑死测定和呼吸暂停检测的挑战

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Introduction: Apnea testing remains essential for the clinical evaluation of brain death determination. In patients who test positive for SARS-CoV-2, disconnecting the patient from the ventilator and introducing high flow oxygen into the endotracheal tube increases the risk for aerosolization of airway secretions and exposure of the examiner. Methods: Case report of a patient with an intracerebral hemorrhage that evolved to significant cerebral edema and herniation, who underwent apnea test using a method involving a t-piece and an HME filter. Results: Patient successfully pronounced brain dead using a safe method to minimize exposure to SARS-CoV-2. Conclusion: At a time where healthcare workers are at high risk of exposure to COVID-19, the above described method is a safe process for apnea testing in declaration of brain death.
机译：导言：呼吸暂停试验对于脑死亡判定的临床评估仍然至关重要。在SARS-CoV-2检测呈阳性的患者中，将患者与呼吸机断开，并将高流量氧气引入气管插管，增加了气道分泌物雾化和检查人员暴露的风险。方法：一例脑出血患者的病例报告，该患者发展为严重的脑水肿和脑疝，使用t形片和HME过滤器进行呼吸暂停试验。结果：患者通过一种安全的方法成功宣布脑死亡，以尽量减少SARS-CoV-2的暴露。结论：在2019冠状病毒疾病高危人群中，上述方法是一种安全的呼吸暂停测试方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号